DIRS.INFO The most relevant business & tech news

☆ Insider Today: Analyzing Google salaries
▼ + stars: | 2023-09-08 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +9 min

In today's big story, we're taking a deeper look at the leaked Google salary data by looking at pay ranges across various factors. The sheet detailed 2022 base salaries, equity, and bonuses from over 12,000 Google employees in the US. Google employees who identified as being of Black/African descent had a median base salary at least $23,000 below their Asian, White, and Middle Eastern/North African colleagues. The gap didn't improve among software engineers, as those of Black/African descent had a median base salary $24,500 lower than those of white or European descent. Google employees who identified as being of Black/African descent had a median base salary at least $23,000 below their Asian, White, and Middle Eastern/North African colleagues.

Persons: We've, Tayfun, Rosalie Chan, Hugh Langley, Madison Hoff, Rosalie, Hugh, Madison, Shaw, Ned Davis, Ryan Salame, Salame, Sam Bankman, Tim Cook, Stephen Lam, Sam Altman, Investor Ford Smith, biohacking, Melissa Phillippi, missteps, Goldman Sachs, Sasha Kelemen, Olivia Rodrigo's, Ralph Lauren, —, Joe Jonas, she'd, Dan DeFrancesco, Naga Siu, Hallam Bullock, Lisa Ryan Organizations: Service, Anadolu Agency, Getty, Google, Google's New, Citadel, Ned Davis Research, Wall, Zen, Apple, Reuters Apple, European Commission, Investor, Leerink Partners, York, Kroger Locations: Wall, Silicon, Madison, Google's New York, Bay, Brooklyn, Manhattan , New York City, USA, China, New York City, San Diego, London, New York

☆ Here are the 14 stocks Jim Cramer is watching, including Oracle, Roku and Southwest
▼ + stars: | 2023-09-06 | by ( Jim Cramer | ) www.cnbc.com time to read: +1 min

In prepared remarks for a speech, she said the Fed is "well positioned to proceed cautiously in this uncertain economic environment." Those sentiments mesh with recent statements from Fed Chairman Jerome Powell and Fed Gov. I did not hear a resounding endorsement of the 27.5% tariffs on Chinese EVs. If you like this story, sign up for Jim Cramer's Top 10 Morning Thoughts on the Market email newsletter for free. Thermo Fisher ScientificUBS downgrades "sainted" Block ToastMorgan Stanley goes equal weight from underweight (hold from sell) on First SolarAeroVironmentSouthwest Airlines

Persons: Susan Collins, Jerome Powell, Christopher Waller, Gina Raimondo, Jim Cramer's, Leerink, Morgan Stanley Organizations: Boston Federal, Fed, Oracle, Microsoft, Fisher Scientific UBS

☆ The Investing Club's top 10 things to watch in the stock market Friday
▼ + stars: | 2023-07-21 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

The Club's top 10 things to watch Friday, July 21 1. Morgan Stanley raised its price target on Eli Lilly to $560 a share, up from $551. KeyBanc raised its price target on Club holding Palo Alto Networks (PANW) to $285 a share, from $242, while maintaining an overweight weighting on the stock. Stifel raised its price target on Club holding Meta Platforms (META) to $336 a share, from $280, while maintaining a buy rating on the stock. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: it's, Z, Morgan Stanley, Eli Lilly, KeyBanc, SLB, Halliburton, SVB Leerink, Johnson, Stifel, DA Davidson, Jim Cramer's, Jim Cramer, Jim Organizations: Nasdaq, American Express, Novo Nordisk, Palo Alto Networks, Johnson, . Railroad, CSX, Microsoft, Jim Cramer's Charitable, CNBC Locations: millennials

☆ Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict
▼ + stars: | 2023-07-21 | by ( Paulina Likos | ) www.cnbc.com time to read: +7 min

But on Tuesday, J & J was ordered to pay $18.8 million after jurors found in favor of 24-year-old Emory Hernandez Valadez who claimed in his lawsuit that he developed mesothelioma, a deadly cancer linked to asbestos, from exposure to J & J talc products. J & J has said that over 60,000 claimants support its latest $8.9 billion settlement to be paid out over 25 years. Johnson & Johnson issued an official statement following the verdict in favor of Valdez, intending to appeal. Even so, J & J got a few of price target increases on Wall Street on Friday. The higher growth pharmaceuticals and medical technology businesses are remaining as the new J & J.

Persons: Johnson, J's, Jim Cramer, Jim, J, Emory Hernandez Valadez, we're, there's, Moshe Maimon, Levy, Maimon, Michael Kaplan, Kaplan, Erik Haas, Thursday's, Haas, Jim Cramer's, Justin Sullivan Organizations: Johnson, LTL Management, J, Credit Suisse, AAA, CNBC, & ' $, & $ Locations: California, American, Levy Konigsberg, Valdez, Stifel, Kenvue, San Anselmo , California

NEW YORK, June 29 (Reuters) - A U.S. bankruptcy judge said Thursday that he would allow SVB Financial Group to sell its investment banking division, once the company has ensured that it is not releasing any liabilities related to the collapse of its Silicon Valley Bank unit. James Bromley, an attorney for SVB Financial, told Glenn that it would remove the liability releases from the deal by Friday. SVB Financial owned Silicon Valley Bank before it was seized by the U.S. Federal Deposit Insurance Corporation (FDIC) in March, and it is attempting to sell its remaining assets in bankruptcy. Glenn also criticized the FDIC during the court hearing, saying he would not allow the agency to block SVB Financial from getting information about its seizure of about $2 billion from SVB Financial' s bank accounts. Silicon Valley Bank's failure in March triggered the worst U.S. banking crisis in 15 years.

Persons: Martin Glenn, Jeff Leerink, Glenn, James Bromley, SVB, you'd, I'm, Erik Bond, Dietrich Knauth, Alexia Garamfalvi, Diane Craft Organizations: YORK, SVB, Bank, Bankruptcy, SVB Securities, Baupost, Silicon Valley Bank, U.S . Federal Deposit Insurance Corporation, FDIC, Citizens, Thomson Locations: Manhattan, Silicon, U.S, backstop

☆ SVB agrees to sell its investment banking division
▼ + stars: | 2023-06-18 | by ( ) www.reuters.com time to read: +1 min

June 18 (Reuters) - SVB Financial Group (SIVBQ.PK) said on Sunday it has entered into an agreement to sell its investment banking division, SVB Securities, to a group led by Jeff Leerink and backed by funds managed by The Baupost Group. The bidder group led by Leerink, who is chief executive of SVB Securities, will acquire the investment banking business for a combination of cash, repayment of an intercompany note, and a 5% equity instrument, the company said. First Citizens BancShares Inc (FCNCA.O) bought all the loans and deposits of the failed bank in March, leaving some $90 billion in securities with the FDIC for sale. The lender continues to evaluate strategic alternatives for its division, SVB Capital, and company's other assets and investments, it said. Reporting by Akanksha Khushi in Bengaluru; Editing by Leslie AdlerOur Standards: The Thomson Reuters Trust Principles.

Persons: Jeff Leerink, Leerink, Akanksha, Leslie Adler Organizations: SVB Financial, SVB Securities, Baupost, Federal Deposit Insurance Corporation, Silicon Valley Bank, BancShares Inc, SVB, Suisse, UBS, Thomson Locations: SVB, reverberated, Bengaluru

☆ A juicy lawsuit offers a window into a Wall Street hiring raid after HSBC took 40+ bankers from the remnants of SVB
▼ + stars: | 2023-05-22 | by ( Matt Turner | ) www.businessinsider.com time to read: +4 min

HSBC hired more than 40 SVB bankers after the California bank was acquired out of receivership. First Citizens, which acquired SVB in the US, is now suing HSBC. The lawsuit offers a rare window into a Wall Street hiring raid. That's at the heart of a new lawsuit accusing HSBC of poaching more than 40 bankers from the failed California bank. Around March 21, per the lawsuit, Sabow met with several of the core leaders he had identified to discuss Project Colony.

☆ SVB is still looking for a buyer. Here is what we know so far.
▼ + stars: | 2023-03-13 | by ( Hayley Cuccinello | ) www.businessinsider.com time to read: +5 min

The weekend came and went without a buyer for SVB Financial Group, the parent company of the failed Silicon Valley Bank. SVB Capital focuses on venture capital and credit investing and SVB Securities is its investment banking arm. Axios reported Monday morning that JPMorgan and PNC were in talks to acquire SVB Financial Group but not the failed commercial bank. SVB Securities, better known as SVB Leerink, the investment banking arm born out of SVB's 2018 acquisition of Leerink, is a very desirable business, he added. "SVB Leerink is a well-known name in the tech and healthcare space that will be attractive to someone," said Healy.

☆ Silicon Valley Bank’s investment banking arm explores buying firm back -Bloomberg News
▼ + stars: | 2023-03-12 | by ( ) www.reuters.com time to read: 1 min

March 11 (Reuters) - The managers of Silicon Valley Bank’s (SIVB.O) investment banking arm, SVB Securities Management, are exploring ways to buy the firm back from its parent, Bloomberg News reported on Saturday, citing people familiar with the matter. The head of SVB Securities, Jeff Leerink, and his team are seeking help to finance a potential management buyout of the business, the report said, adding that they are rushing to do a speedy deal as regulators seek a buyout for the remnants of SVB Financial Group. Reporting by Kanjyik Ghosh in Bengaluru; editing by Grant McCoolOur Standards: The Thomson Reuters Trust Principles.

☆ Who will step up to buy SVB? The white knight might be a bank outside Wall Street.
▼ + stars: | 2023-03-11 | by ( Hayley Cuccinello | ) www.businessinsider.com time to read: +5 min

SVB Bank, which catered to startups and tech founders, imploded in three days after a run on the bank. SVB Financial is reportedly looking to find a buyer by Monday. The implosion of Silicon Valley Bank means a working weekend for some bankers. SVB Financial Group is on the hunt for a buyer after regulators closed its Silicon Valley Banking business, according to Bloomberg. Though SVB's bond losses are taking up the headlines, its parent company SVB Financial has two business segments that are enticing.

☆ How SVB employees are coping after being ordered to leave the office, from polishing their resumes to hitting the bar: 'We're pretty much in the dark'
▼ + stars: | 2023-03-10 | by ( Emmalyse Brownstein | Rebecca Ungarino | Carter Johnson | ) www.businessinsider.com time to read: +6 min

It read: "Operations of the SVB Securities broker dealer are distinct from the receivership of SVB Financial." The SVB Securities employee called the whirlwind leading up to SVB's meltdown as "scary, scary stuff." Kevin Heal, senior analyst at Argus Research, said he sees both SVB Securities and SVB Private being sold. SVB bought the healthcare investment bank Leerink Partners in 2018, renaming it SVB Leerink and then SVB Securities. PATRICK T. FALLON/AFP via Getty ImagesHeal thinks the investment banking operations could be purchased by a smaller investment banking firm that doesn't have tech or healthcare prowess, like US Bancorp or PNC.

☆ Jim Cramer's top 10 things to watch in the market Friday: More selling, Estee Lauder, Meta Platforms
▼ + stars: | 2022-12-16 | by ( Jim Cramer | ) www.cnbc.com time to read: +3 min

Atlantic Equities expects growth at Club holding Estee Lauder (EL) to reaccelerate as China relaxes Covid restrictions. JPMorgan names AbbVie (ABBV) and Club holding Eli Lilly (LLY) as best in class and top picks in biopharma for 2023. Club holding Apple (AAPL) named a top tech pick at Evercore ISI. Barclays raises price target on General Electric (GE) to $96 per share from $92 ahead of the health-care spin-off. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ A former Harvard chemist just raised $178 million for a biotech startup that plans to treat previously untreatable cancers
▼ + stars: | 2022-11-21 | by ( Andrew Dunn | ) www.businessinsider.com time to read: +6 min

The biotech FogPharma has raised $178 million in a Series D round. The longtime Harvard chemist Greg Verdine founded Fog to tackle "undruggable" cancers. Fog's drugs, known as polypeptides or short fragments of proteins, blur the line between small molecules and biologics, sharing characteristics of both types of medicines. Verdine calls it "the magic structure" for Fog's drugs. "I thought he'd be able to find things that bind, but I was very skeptical that he could turn them into drugs," Klausner told Insider.

☆ Analysis: Falling demand for COVID boosters puts price hikes on the table
▼ + stars: | 2022-10-20 | by ( Michael Erman | ) www.reuters.com time to read: +5 min

Last year, many on Wall Street were estimating the number of COVID-19 shots would be in line with the annual flu vaccine, which is the vaccine market leader with more than 160 million shots per year in the United States and 600 million shots globally. A recent poll by Kaiser Family Foundation found that two-thirds of American adults do not plan on getting a COVID vaccine soon. He added that instances of COVID infections in those who have been vaccinated has left many to question the effectiveness of the vaccine. The companies could make up for some of the weaker demand with price increases. That would mean annual revenue of $3 billion to $5 billion over the long-term for a company like Moderna, he added.

☆ 3 takeaways from our daily meeting: Still oversold, picking at chip stocks, Club names in the news
▼ + stars: | 2022-09-30 | by ( Krystal Hur | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Market still oversold When to buy chip Quick mentions: TJX, DIS, ABBV 1. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Profituri de miliarde din afacerile cu vaccin
▼ + stars: | 2021-03-24 | by ( ) capital.market.md time to read: +9 min

Analiştii SVB Leerink estimează vânzări de 1,9 miliarde de dolari în acest an şi 3 miliarde de dolari în 2022. Acestea ar urma să fie mult mai mari dacă AstraZeneca va livra ambiţioasa sa ţintă de 3 miliarde de doze. La 4 martie, R. Moldova a recepţionat 14 400 doze de vaccin AstraZeneca livrate gratuit în cadrul mecanismului COVAX. Ministerul mai informează că, prin intermediul platformei COVAX, R. Moldova va primi 24 570 doze de vaccin Pfizer şi 264 000 doze de vaccin AstraZeneca. Anterior 21 600 doze de vaccin AstraZeneca au fost livrate, ca ajutor umanitar, din România, din cele 200 000 doze de vaccin promise.

Persons: Agenţia, Pfizer, Alan Carr, Johnson, Analiştii, Preţul, Aureliu Ciocoi, Janssen, Tatiana Zatîc, Vlad Organizations: euro, SUA, Pandemia, Medical Electronics, Guardian, Reuters, Uniunea Europeană, UE, Moderna, Uniunii Europene, Financial Times, Naţionale, Comitetului, OMS, Sk Bio, Center, Sputnik Locations: UE, FMI, SUA, Germania, China, preţul, Indonezia, Ungaria, Slovacia, Iran, Algeria, Mexic, Rusiei, Rusia, Republica Moldova, Moldova, România, şedinţă, UK, Sinopharm, Sinovac, Moderna

Search resuls for: "Leerink"

16 mentions found